Prospectus

Pelthos Therapeutics Inc. Filed 2024-02-20 Acc 0001753926-24-000342

Documents 1

2024-02-23 4 Options or other derivatives
2024-02-23 4 Director acquired 29,167 shares (option exercise)
2024-02-23 4 Director acquired 20,641 shares (option exercise)
2024-02-22 8-K Material agreement · Unregistered share sale · Bylaws or fiscal year change · Other events
2024-02-20 SEC STAFF LETTER SEC Staff Letter Redacted Exhibit
2024-02-20 424B4 Prospectus
2024-02-20 424B4 Prospectus

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading g084065_424b4.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…